PubMed Health⌕ Search

PubMed · 10910777

Classifying depression: should paradigms lost be regained?

Abstract

OBJECTIVE: Classification of the depressive disorders has long been controversial. The dominant current model is unitarian, with disorders largely distinguished on the basis of severity. Both the unitarian and the contrasting binarian views (of two principal types) have proved to be unsatisfactory. The binarian model's procrustean requirements are too inflexible to address the evident heterogeneity contributed to by clinical manifestations and underlying personality features. METHOD: This article briefly reviews the historically favored unitarian and binarian viewpoints on classification of depression. RESULTS: The author argues that the "final common pathway" model, articulated in the early 1970s, helped to cement psychiatric classification in subsequent DSM and ICD revisions into a unitarian framework, leading to a relatively sterile period of depression research. Clinically described depressive typologies were obscured rather than refined by appropriate modeling paradigms. A contrasting, empirically based hierarchical model, driven by disorder-specific clinical manifestations such as psychotic features and observable psychomotor disturbance, is proposed as a paradigm for distinguishing psychotic, melancholic, and nonmelancholic classes of depression, while a spectrum model is favored for distinguishing the principal nonmelancholic subclasses. CONCLUSIONS: Resolution of the better paradigm requires that the two models undergo comparative testing in applied studies, particularly ones pursuing neurobiological determinants and differential responses to antidepressant treatments.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Parker. 2000. Classifying depression: should paradigms lost be regained?. https://doi.org/10.1176/appi.ajp.157.8.1195

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Psychological morbidity and female urinary incontinence.

Female urinary incontinence is a common yet distressing condition. It affects women of all ages, but is especially common in the elderly. Its prevalence ranges from 15 to 55%, depending on age and population studied. Despite the ubiquity of female urinary incontinence, many incontinent women do not voice their suffering, and urinary incontinence has therefore been dubbed 'the silent epidemic'. The physical impact and social isolation associated with urinary incontinence lead to impairment of quality of life and psychological well-being. It is the aim of this review to discuss the epidemiology and psychological impact of urinary incontinence. The recognition and management of incontinence-related psychological morbidity are also explored.

Depressive Disorder↗

Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings.

Vagus nerve stimulation (VNS) therapy is an effective adjunctive treatment for chronic or recurrent treatment-resistant depression in adults, and for pharmacoresistant epilepsy in adults and adolescents. VNS therapy is administered through an implanted pulse generator that delivers programmed electrical pulses through an implanted lead to the left vagus nerve. Programmable pulse parameters include output current, frequency, pulse width, and ON/OFF times. Within a range of typical values, individual patients respond best to different combinations of parameter settings. The physician must identify the optimum settings for each patient while balancing the goals of maximizing efficacy, minimizing side effects, and preserving battery life. Output current is gradually increased from 0.25 mA to the maximum tolerable level (maximum, 3.5 mA); typical therapeutic settings range from 1.0 to 1.5 mA. Greater output current is associated with increased side effects, including voice alteration, cough, a feeling of throat tightening, and dyspnea. Frequency is typically programmed at 20 Hz in depression and 30 Hz in epilepsy. Pulse width is typically 250 or 500 micros. The recommended initial ON time is 30 s, followed by 5 min OFF; OFF time > ON time is recommended. As with pharmacotherapy, VNS therapy must be adjusted in a gradual, systematic fashion to individualize therapy for each patient.

Depressive Disorder↗